In Vitro, In Vivo Pharmacology & In Vivo Imaging Solutions
Adgyl Lifesciences provides GLP and non-GLP pharmacology and efficacy studies using in vitro and in vivo models to efficiently support drug development and regulatory submissions. With our cutting-edge imaging facility, we also offer highly sensitive and reliable in vivo imaging data. We have a proven track record of delivering drug discovery and proof-of-concept studies for global clients within defined timelines and cost.
Comprehensive In Vitro, In Vivo Pharmacology & In Vivo Imaging Solutions
Our human-relevant in vitro testing using isolated tissues, along with over 200 rodent efficacy models across various disease areas including oncology and immunooncology, translational research (humanized mouse models), and others, supports your drug discovery process. Our state-of-the-art in vivo imaging platform enables real-time drug biodistribution analysis and 3D optical tomography.
Pharmacology Models
In Vivo Pharmacology Studies
Adgyl Lifesciences offers a portfolio of over 200 efficacy models, supporting research across a wide range of therapeutic areas, including:
- Oncology & immuno-oncology
- Metabolic disorders (Diabetes, obesity, hyperlipidaemia animal models)
- Cardiovascular disease
- CNS disorders
- Fibrosis (Lung, liver and kidney)
- Kidney disorders
- Wound healing
- Gastrointestinal (GI) disease
- Pain models
- Inflammation and autoimmune diseases
- Ocular pharmacology
- Surgical skills – in vivo
Adgyl Lifesciences offers following studies:
Advanced In Vivo Imaging for Real-time Insights
Our state-of-art in vivo imaging platform delivers fast, sensitive, and non-invasive real-time quantitative assessments of drug efficacy, monitor biodistribution, track drugs, spread of a disease. Accelerate your drug discovery and development with innovative in vivo imaging systems.
Key imaging applications include:
- Real-time biodistribution
- Bioluminescence Imaging (BLI) and Fluorescence Imaging(FLI)
- 3D Optical tomography
- Ex-vivo imaging
Scientific Partnership
Partnering for Scientific Excellence
Adgyl Lifesciences is committed to ensure
Scientifically rigorous, reproducible and timely study execution.
High‑quality data generation aligned with scientific & regulatory requirements
Seamless end‑to‑end support spanning study design, execution, and data interpretation.
Connect with our expert team today to discuss how we can support your in vitro, in vivo pharmacology, and imaging needs.
what people ask
Frequently Asked Questions
What pharmacology services does Adgyl Lifesciences offer?
We provide GLP and non‑GLP in vitro and in vivo pharmacology and efficacy studies, supported by advanced in vivo imaging solutions to efficiently support drug development and regulatory submissions.
How extensive is your pharmacology model portfolio?
We offer a portfolio of over 200 validated in vivo efficacy models, supported by strong surgical expertise and in vivo model development capabilities.
Can imaging studies be integrated with pharmacology and efficacy models?
Yes. Our imaging capabilities are fully integrated with in vivo pharmacology and efficacy studies, allowing longitudinal monitoring and improved translational insights within the same study.
How do clients collaborate with Adgyl Lifesciences?
We work closely with clients to design customised study strategies, aligned with scientific objectives, timelines, and regulatory expectations, ensuring transparent communication and efficient project execution.
How does Adgyl Lifesciences ensure timely and cost‑effective project delivery?
Through validated models, integrated in vitro, in vivo, and imaging capabilities, and efficient study execution, we consistently deliver projects within defined timelines and cost.
